NSAIDs Begin Reducing Pain Within 2 Hours
NSAIDs provide measurable pain relief within less than 2 hours of administration, with oral NSAIDs reducing pain by approximately 0.93 cm on a 10-cm pain scale compared to placebo 1.
Timeline of Pain Relief
Immediate-Term Relief (< 2 Hours)
- Oral NSAIDs: Moderate-certainty evidence demonstrates pain reduction of 0.93 cm (95% CI -1.49 to -0.37 cm) on a 10-cm visual analog scale within 2 hours 1
- Topical NSAIDs: Similar efficacy with 1.02 cm reduction (95% CI -1.64 to -0.39 cm) within 2 hours 1
- Topical NSAIDs plus menthol gel: Enhanced effect with 1.68 cm reduction within 2 hours 1
Short-Term Relief (1-7 Days)
- Oral NSAIDs: Sustained pain reduction of 0.99 cm (95% CI -1.46 to -0.52 cm) at 1-7 days 1
- Topical NSAIDs: Maintained efficacy with 1.08 cm reduction at 1-7 days 1
Important Clinical Context
The onset of NSAID effect may be delayed by 30-60 minutes due to pharmacokinetic factors 2. This means:
- Peak analgesic effect occurs after initial absorption and distribution
- The opioid-sparing effect is not apparent until approximately 4 hours after administration 2
- For predictable pain episodes (e.g., movement-related pain), immediate-release formulations should be administered at least 20 minutes before the anticipated pain trigger 3
Practical Application
For acute musculoskeletal injuries, the American College of Physicians and American Academy of Family Physicians strongly recommend topical NSAIDs with or without menthol gel as first-line therapy, with oral NSAIDs as an alternative 1. The evidence shows:
- Pain relief begins within the first 2 hours
- Continued improvement through the first week
- High-certainty evidence for disability improvement (RMDQ reduction of 2.02 points) 1
Critical Caveats
While NSAIDs work quickly, use the lowest effective dose for the shortest duration 4. The guideline panel emphasizes:
- Re-evaluate patient requirements and response periodically 4
- In patients with increased GI risk, use non-selective NSAIDs plus gastroprotective agents or selective COX-2 inhibitors 4
- COX-2 inhibitors are contraindicated in patients with increased cardiovascular risk 4
- Monitor for renal, hepatic, and cardiovascular toxicities, particularly in older adults (age ≥60 years) 5, 6
The small magnitude of pain reduction (approximately 1 cm on a 10-cm scale) may not be clinically meaningful for all patients, though the effect is statistically significant and consistent across multiple high-quality trials 1.